ES2064319T3 - Produccion de itsp humano recombinante. - Google Patents

Produccion de itsp humano recombinante.

Info

Publication number
ES2064319T3
ES2064319T3 ES87309087T ES87309087T ES2064319T3 ES 2064319 T3 ES2064319 T3 ES 2064319T3 ES 87309087 T ES87309087 T ES 87309087T ES 87309087 T ES87309087 T ES 87309087T ES 2064319 T3 ES2064319 T3 ES 2064319T3
Authority
ES
Spain
Prior art keywords
production
itsp
recombinant human
psti
human psti
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87309087T
Other languages
English (en)
Inventor
Michio Ogawa
Kenichi Matsubara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Application granted granted Critical
Publication of ES2064319T3 publication Critical patent/ES2064319T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8135—Kazal type inhibitors, e.g. pancreatic secretory inhibitor, ovomucoid
    • E—FIXED CONSTRUCTIONS
    • E03—WATER SUPPLY; SEWERAGE
    • E03B—INSTALLATIONS OR METHODS FOR OBTAINING, COLLECTING, OR DISTRIBUTING WATER
    • E03B3/00—Methods or installations for obtaining or collecting drinking water or tap water
    • E03B3/06—Methods or installations for obtaining or collecting drinking water or tap water from underground
    • E03B3/08—Obtaining and confining water by means of wells
    • E—FIXED CONSTRUCTIONS
    • E03—WATER SUPPLY; SEWERAGE
    • E03B—INSTALLATIONS OR METHODS FOR OBTAINING, COLLECTING, OR DISTRIBUTING WATER
    • E03B3/00—Methods or installations for obtaining or collecting drinking water or tap water
    • E03B3/40—Other devices for confining, e.g. trenches, drainage
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Water Supply & Treatment (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Hydrology & Water Resources (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Environmental & Geological Engineering (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

UN PROCEDIMIENTO PARA LA OBTENCION DE PSTI HUMANO, QUE CONSISTE EN TRANSFORMAR SACCHAROMYCES CEREVISAE CON UN VECTOR QUE LLEVA UN PSTI HUMANO QUE CODIFICA GENE Y CULTIVAR EL TRANSFORMADO RESULTANTE EN CONDICIONES ADECUADAS. LA INVENCION TAMBIEN INCLUYE UN PSTI HUMANO, PURO, POLIPEPTIDOS DE PSTI CON Y SIN SECUENCIAS DIRECTAS Y SU USO Y DNAS CORRESPONDIENTES.
ES87309087T 1986-10-14 1987-10-14 Produccion de itsp humano recombinante. Expired - Lifetime ES2064319T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61245049A JPH0616716B2 (ja) 1986-10-14 1986-10-14 酵母におけるヒトｐｓｔｉの製造法

Publications (1)

Publication Number Publication Date
ES2064319T3 true ES2064319T3 (es) 1995-02-01

Family

ID=17127817

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87309087T Expired - Lifetime ES2064319T3 (es) 1986-10-14 1987-10-14 Produccion de itsp humano recombinante.

Country Status (8)

Country Link
EP (1) EP0267692B1 (es)
JP (1) JPH0616716B2 (es)
KR (1) KR950010817B1 (es)
AT (1) ATE111955T1 (es)
AU (1) AU597115B2 (es)
CA (1) CA1340393C (es)
DE (1) DE3750571T2 (es)
ES (1) ES2064319T3 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1339736C (en) * 1986-10-14 1998-03-17 Shionogi & Co., Ltd. Method for preparing fusion proteins
AU8172787A (en) * 1986-10-30 1988-05-25 Synergen Biologicals, Inc. Human pancreatic secretory trypsin inhibitors produced by recombinant dna methods and processes for the production of same
GB2199582A (en) * 1987-01-07 1988-07-13 Bayer Ag Analogues of pancreatic secretory trypsin inhibitor
JPS6427473A (en) * 1987-07-23 1989-01-30 Mochida Pharm Co Ltd Human pancreas-secreting trypsin inhibitor and production thereof
GB2208511A (en) * 1987-08-07 1989-04-05 Bayer Ag Variants of bovine pancreatic trypsin inhibitor produced by recombinant dna technology
DE3907492A1 (de) * 1989-03-08 1990-09-13 Biotechnolog Forschung Gmbh Verfahren zur isolierung und reinigung von hpsti und hpsti-varianten

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775622A (en) * 1982-03-08 1988-10-04 Genentech, Inc. Expression, processing and secretion of heterologous protein by yeast
EP0561137B1 (en) * 1983-04-25 2002-07-03 Chiron Corporation Hybrid DNA Synthesis of Mature Insulin-like Growth Factors
JPS6041487A (ja) * 1983-04-25 1985-03-05 ジエネンテツク・インコ−ポレイテツド 酵母発現系でのアルフア因子配列の使用
ATE64956T1 (de) * 1984-06-14 1991-07-15 Ciba Geigy Ag Verfahren zur herstellung von thrombininhibitoren.
AU590238B2 (en) * 1984-12-06 1989-11-02 Amgen, Inc. Recombinant methods for production of serine protease inhibitors and dna sequences useful for same
CA1339736C (en) * 1986-10-14 1998-03-17 Shionogi & Co., Ltd. Method for preparing fusion proteins
AU8172787A (en) * 1986-10-30 1988-05-25 Synergen Biologicals, Inc. Human pancreatic secretory trypsin inhibitors produced by recombinant dna methods and processes for the production of same

Also Published As

Publication number Publication date
AU597115B2 (en) 1990-05-24
JPH0616716B2 (ja) 1994-03-09
KR950010817B1 (ko) 1995-09-23
EP0267692A3 (en) 1989-10-25
AU7976487A (en) 1988-04-28
EP0267692B1 (en) 1994-09-21
KR880005264A (ko) 1988-06-28
JPS6398397A (ja) 1988-04-28
EP0267692A2 (en) 1988-05-18
DE3750571D1 (de) 1994-10-27
ATE111955T1 (de) 1994-10-15
CA1340393C (en) 1999-02-16
DE3750571T2 (de) 1995-03-30

Similar Documents

Publication Publication Date Title
LU91304I2 (fr) A tryn-antithrombin alfa
NZ222450A (en) Synthetic dna, peptide synthesis and regulation of transcription of silk like protein
HUT46061A (en) Dna sequences encoding hirudin-like protein and process for producing such proteins
DE3884356D1 (de) Verfahren zur Herstellung von Fremdprotein in Hefe, Rekombinant DNS, Transformant.
NO177863C (no) Fremgangsmåte for fremstilling av rekombinant humant IFN-type I, IFN1, IFN-pseudo-2, -3, og -4, samt ekspresjonsvektorer
DE69013811T2 (de) Verfahren zur Herstellung von antiviralem Protein unter Benützung von E.coli-Transformant, das Gen, das für dieses Protein kodiert und E.coli-Vektor benützt in diesem Verfahren.
DE3855449T2 (de) DNS-Klone von menschlichem Thrombomodulin
GR3024316T3 (en) Novel polypeptides, the DNA sequences allowing their expression, method of preparation, and utilization
ES2064319T3 (es) Produccion de itsp humano recombinante.
NO177570B (no) Fremgangsmåte ved fremstilling av peptider med fibronektinbindende egenskaper, mikroorganisme og DNA-sekvens som koder for peptider med fibronektinbindende egenskaper
DE68922891T2 (de) D-Aminosäureoxidase.
ES2081807T3 (es) Enzima recombinante de alfa-amidacion de c-terminales.
GB8726953D0 (en) Yeast expression system
EP0317627A4 (en) Oncogene-encoded polypeptide having growth factor activity and methods of production and use thereof
ES2093606T3 (es) Gen del receptor de celulas t localizado en el locus alfa y estructuras artificiales de adn.
ATE175237T1 (de) Polypeptide beteiligt an der kobalamin- und/oder kobamid-biosynthese, für diese kodierende dns- sequencen, und ihre herstellung und vewendung.
AU7880987A (en) Human B-cell differentiation factor and process of producing said factor
ATE386114T1 (de) Gene, die für lymphocyte spezifischen interferon- regulationsfaktor (lsirf) polypeptide kodiert

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 267692

Country of ref document: ES